相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative analysis of antioxidant and antiproliferative activities of crude and purified flavonoid enriched fractions of pods/seeds of two desert legumes Prosopis cineraria and Cyamopsis tetragonoloba
Vidushi Asati et al.
HELIYON (2021)
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
Heena Saini et al.
CANCER CELL INTERNATIONAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Exploring the extensive crosstalk between the antagonistic cytokines- TGF-β and TNF-α in regulating cancer pathogenesis
Subhra Dash et al.
CYTOKINE (2021)
Systematic investigation of cytokine signaling activity at the tissue and single-cell levels
Peng Jiang et al.
NATURE METHODS (2021)
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
Jeff Yat-Fai Chung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Ester Gonzalez-Sanchez et al.
CANCERS (2021)
Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
Faisal Adnan et al.
INFECTIOUS AGENTS AND CANCER (2020)
The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma
Kanghyug Choi et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Interleukin-6: A Masterplayer in the Cytokine Network
Peter Uciechowski et al.
ONCOLOGY (2020)
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Sudha Suriyamurthy et al.
CANCERS (2019)
TGF-β dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression
R. Wiegertjes et al.
OSTEOARTHRITIS AND CARTILAGE (2019)
Contextual Regulation of TGF-β Signaling in Liver Cancer
Shuo Tu et al.
CELLS (2019)
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yoon Mee Yang et al.
SEMINARS IN LIVER DISEASE (2019)
Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
Heena Saini et al.
JOURNAL OF ONCOLOGY (2019)
E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2-M phase transition
Jingjie Sun et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Shaofei Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
TGF-β2-induced EMT is dampened by inhibition of autophagy and TNF-α treatment
Subhra Dash et al.
Oncotarget (2018)
Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells
Mulugeta M. Zegeye et al.
CELL COMMUNICATION AND SIGNALING (2018)
CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis
Xiaobo Cai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
Cesidio Giuliani et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
Joanne Marie O'Rourke et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis
Ebrahim Shakiba et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2018)
Involvement of inflammation and its related microRNAs in hepatocellular carcinoma
Ke Jin et al.
ONCOTARGET (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration
Jie Zhou et al.
MOLECULAR MEDICINE REPORTS (2017)
High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients
Li Peng et al.
ONCOTARGET (2017)
Males develop faster and more severe hepatocellular carcinoma than females in krasV12 transgenic zebrafish
Yan Li et al.
SCIENTIFIC REPORTS (2017)
Biosynthesized Protein-Capped Silver Nanoparticles Induce ROS-Dependent Proapoptotic Signals and Prosurvival Autophagy in Cancer Cells
Leena Fageria et al.
ACS OMEGA (2017)
STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer
Yuan-Ming Pan et al.
MOLECULAR CANCER (2016)
Huge hepatocellular carcinoma with multiple intrahepatic metastases: An aggressive multimodal treatment
Satoshi Yasuda et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?
Akinobu Takaki et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Serum interleukin-6 associated with hepatocellular carcinoma risk: A nested case-control study
Waka Ohishi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma
Jin-Wei Miao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer
Parvin Ataie-Kachoie et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Rather than Rs1800796 Polymorphism, Expression of Interleukin-6 Is Associated with Disease Progression of Chronic HBV Infection in a Chinese Han Population
Shengli Tang et al.
DISEASE MARKERS (2013)
Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer
Daisaku Yamada et al.
EUROPEAN JOURNAL OF CANCER (2013)
The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
Daria Capece et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma
Jeong Won Jang et al.
CYTOKINE (2012)
Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma
Danbi Lee et al.
ONCOLOGY (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma
Tom Luedde et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Cell Cycle Arrest by Transforming Growth Factor β1 near G1/S Is Mediated by Acute Abrogation of Prereplication Complex Activation Involving an Rb-MCM Interaction
Piyali Mukherjee et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
Zhan Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
Maureen M. Sherry et al.
STEM CELLS (2009)
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
Nuria de la Iglesia et al.
GENES & DEVELOPMENT (2008)
Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
Cedric Coulouarn et al.
HEPATOLOGY (2008)
Interleukin-6 mediates G0/G1 growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway
Dairmuid M. Moran et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
C. Porta et al.
ANNALS OF ONCOLOGY (2008)
Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma
Pisit Tangkijvanich et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells
Takeharu Kanazawa et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice
Narci Teoh et al.
JOURNAL OF HEPATOLOGY (2006)
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma
Maurizio Soresi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
STAT3-mediated transcription of Bcl-2, Mcl-1 and c-lAP2 prevents apoptosis in polyamine-depleted cells
S Bhattacharya et al.
BIOCHEMICAL JOURNAL (2005)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Cross-talk between IL-6 and TGF-β signaling in hepatoma cells
T Yamamoto et al.
FEBS LETTERS (2001)
Tumor necrosis factor-α inhibits transforming growth factor-β/Smad signaling in human dermal fibroblasts via AP-1 activation
F Verrecchia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma
GY Chau et al.
ANNALS OF SURGERY (2000)
分享论文
